Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases of liverICD-10-CM k71-toxic-liver-disease
    Ask Trek AI about this page

    ICD-10-CM Code For Toxic Liver Disease: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group K71 includes conditions of toxic liver disease caused by drugs, medicinal agents, and other external chemical substances, covering acute toxic hepatitis, toxic liver failure, and chronic sequelae of toxic injury. These ICD-10-CM diagnosis codes are used to document clinical scenarios such as exposure-related hepatic injury, varying severity from mild transaminitis to acute liver failure, and specific organ system involvement like hepatocellular or cholestatic patterns. Accurate coding within the ICD-10-CM K71 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Toxic Liver Disease: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM K71: Toxic Liver Disease Overview

    The diagnoses in this group represent liver injury caused by toxins, drugs, or other xenobiotics affecting hepatic structure and function. They target the hepatobiliary system and include a range of toxic liver reactions from mild injury to fulminant hepatic failure. Accurate coding is important for complete clinical documentation and supports appropriate reimbursement for services related to toxin-induced liver disease.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when clinical documentation attributes liver dysfunction or failure to a specific toxic agent, drug, or chemical exposure. Codes in this group apply when the medical record specifies the toxin-related etiology and the associated hepatic presentation or complications.

    ICD-10-CM Codes

    12 rows

    ICD-10-CM CodeDescription
    K71.0Toxic liver disease with cholestasis
    K71.10Toxic liver disease with hepatic necrosis, without coma
    K71.11Toxic liver disease with hepatic necrosis, with coma
    K71.2Toxic liver disease with acute hepatitis
    K71.3Toxic liver disease with chronic persistent hepatitis
    K71.4Toxic liver disease with chronic lobular hepatitis
    K71.50Toxic liver disease with chronic active hepatitis without ascites
    K71.51Toxic liver disease with chronic active hepatitis with ascites
    K71.6Toxic liver disease with hepatitis, not elsewhere classified
    K71.7Toxic liver disease with fibrosis and cirrhosis of liver
    K71.8Toxic liver disease with other disorders of liver
    K71.9Toxic liver disease, unspecified

    DRG Codes

    5 rows

    DRG CodeDescription
    441Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis with MCC
    442Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis with CC
    443Disorders of Liver Except Malignancy, Cirrhosis or Alcoholic Hepatitis without CC/MCC
    791Prematurity with Major Problems
    793Full Term Neonate with Major Problems

    Typical Clinical Scenarios

    • An adult presents to the emergency department with acute onset jaundice, right upper quadrant pain, elevated aminotransferases (AST/ALT in the thousands), and a recent history of acetaminophen overdose; the patient has signs of systemic toxicity and is hemodynamically unstable, prompting urgent stabilization and toxicology-directed care. A toxic liver disease diagnosis from this group is assigned to capture acute hepatocellular injury from a known toxic exposure. Typical codes: K71.0, K71.6
    • A middle-aged patient with chronic alcohol misuse is evaluated in outpatient hepatology clinic for progressive fatigue, intermittent jaundice, and persistently abnormal liver enzymes despite abstinence counseling; imaging shows steatosis and fibrosis without viral hepatitis. The clinician documents ongoing toxic injury to the liver related to chronic alcohol use as the underlying cause of the hepatic disease and assigns a category code reflecting toxic liver disease due to chronic exposure. Typical codes: K71.2, K71.3
    • A hospitalized patient with nonalcoholic medication-induced liver injury develops acute liver failure with coagulopathy and hepatic encephalopathy as complications during treatment for an unrelated condition; the toxic agent is suspected but not definitively identified. The diagnosis group is used to code the toxic liver injury as the primary liver pathology and to indicate the presence of hepatic failure or fibrosis as complications when applicable. Typical codes: K71.4, K71.51

    Related Codes

    K70-ALCOHOLIC-LIVER-DISEASE

    ICD-10-CM Code For Alcoholic Liver Disease: Group Overview

    K72-HEPATIC-FAILURE-NOT-ELSEWHERE-CLASSIFIED

    ICD-10-CM Code For Hepatic Failure Not Elsewhere Classified: Group Overview

    K73-CHRONIC-HEPATITIS-NOT-ELSEWHERE-CLASSIFIED

    ICD-10-CM Code For Chronic Hepatitis Not Elsewhere Classified: Group Overview

    K74-FIBROSIS-AND-CIRRHOSIS-OF-LIVER

    ICD-10-CM Code For Fibrosis And Cirrhosis Of Liver: Group Overview

    K75-OTHER-INFLAMMATORY-LIVER-DISEASES

    ICD-10-CM Code For Other Inflammatory Liver Diseases: Group Overview

    K76-OTHER-DISEASES-OF-LIVER

    ICD-10-CM Code For Other Diseases Of Liver: Group Overview

    K77-LIVER-DISORDERS-IN-DISEASES-CLASSIFIED-ELSEWHERE

    ICD-10-CM Code For Liver Disorders In Diseases Classified Elsewhere: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.